Tests to guide weight-loss medication choice for obesity
Part of Hormones & metabolism clinical trials.
This study tests a simple cheek swab that may help doctors pick the most effective weight-loss medication for each person. Participation could help tailor your treatment, potentially improving results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a BMI of 30 or higher, or a BMI of 27 or higher with an obesity-related health condition (like diabetes or high blood pressure).
- You are a Mayo Clinic employee or a dependent of one.
- You have been referred to the Community Internal Medicine Weight Management Program.
- You are not pregnant or breastfeeding.
- You are able to safely take weight-loss medications like Qsymia, Contrave, Saxenda, Wegovy, or Zepbound.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.
This study aims to better understand patients who are prescribed medications like Orlistat, Mysimba, Saxenda, Wegovy, or Mounjaro for obesity. It will help doctors improve treatments for you.
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
This trial looks at whether your genes can predict how well you will respond to weight loss medications like semaglutide (Wegovy/Ozempic) or tirzepatide (Mounjaro). It may help doctors choose the right drug for you based on your DNA.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.